JAMA Network Home
Sign In
Viewpoint

Buprenorphine via Telehealth—Closing the Gap for Pregnant and Postpartum Women With Opioid Use Disorder

JAMA Internal Medicine 10.1001/jamainternmed.2026.4106

September 21, 2026 at 11:00 AM EDT

Read the full article

This Viewpoint calls for further research to guide clinicians and policymakers in increasing access and effective use of telehealth prescribing of buprenorphine for pregnant and postpartum women.

Corresponding Author: Rachel K. Landis, PhD, MPP, RAND, 1200 S Hayes St, Arlington, VA 22202 (rlandis@rand.org).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2026.4106?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=092126

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks